07262017Headline:

Lucrative Asia-Pacific Markets to Offer Significant Growth Opportunities for the Transfection Reagents and Equipment Market in the Coming Years

Growth in the transfection reagents and equipment market is likely to be centered in the Asia-Pacific region. This growth can be attributed to growing economies such as China and India, growing R&D expenditure in Asian countries, and increasing medical research activities in the Asia-Pacific region.

Key players are focusing on the strategies of agreements, collaborations, and partnerships to excel in research & innovation, expand customer base, and enhance their sales & distribution network. Some of the key players that adopted this strategy include MaxCyte, Inc. (U.S.), Polyplus-transfection SA (France), and QIAGEN N.V. (Netherlands).

On the basis of product, the transfection reagents and equipment market is categorized into reagents and instruments. In 2016, the reagents segment is estimated to account for the largest share of the market. However, the instruments segment is expected to grow at the highest CAGR during the forecast period.

On the basis of method, the market is segmented into biochemical, physical, and viral methods. In 2016, the biochemical method segment is expected to account for the largest share of the market, while the viral method segment is expected to grow at the highest CAGR during the forecast period. The biochemical method segment is further classified into calcium phosphate, lipofection, DEAE-Dextran, and dendrimers. Whereas, the physical method segment is further divided into electroporation, nucleofection, and others (gengun, sonoporation, magnetofection, and optoinjection).

On the basis of application, the market is segmented into biomedical research, protein production, and therapeutic delivery. In 2016, the biomedical research segment is estimated to account for the largest share of the market.

On the basis of end user, the market is segmented into academic & research institutes and pharmaceutical & biotechnologies companies. In 2016, the academic & research institutes is expected to account for the largest share of the market. However, the pharmaceutical & biotechnologies companies segment is projected to grow at the highest CAGR during the forecast period.

On the basis of region, the global transfection reagents and equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.

 

What Next?

Recent Articles